Pay in 4 interest-free payments of $17.25 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
) produces robust phase delays
demonstrates robust in vivo efficacy in multiple models
In contrast
most selective 5- HT2B receptor ligands
Toxins (Basel)
MBX-2982 - CAS# 1037792-44-1 size:2mg solid ) produces robust phase delaysMBX 2982, also known as SAR 260093, CAS No. 1037792 44 1, is a potential first in class treatment for type 2 diabetes that targets G protein coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose dependent insulin secretion. Preclinical data indicate that MBX 2982 is a potent selective orally active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the
US$ 133.65
US$ 137.54
US$ 440.00
US$ 285.79
US$ 243.09
US$ 197.42
US$ 133.65